Patient Input and Clinical Experts: Vonvendi

CADTH has received the following notice(s) of pending drug submission(s).

Brand name Vonvendi
Generic name von Willebrand Factor [recombinant]
Manufacturer Shire Pharma Canada ULC, now part of Takeda
Indication(s) von Willebrand disease, adults, treatment and perioperative management
Project Number ST0639-000
Call for patient input 2020-01-02
Patient input deadline 2020-02-21
Submit patient input Submit
Register as Clinical Expert Register